Issue 49, 2018

A mitochondria-targeting hetero-binuclear Ir(iii)–Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells

Abstract

A hetero-binuclear Ir(III)–Pt(II) complex was developed as an antitumor agent. In vitro cytotoxicity results indicated that this complex was effective against cisplatin-resistant tumor cells. Mechanism experiments showed that it can overcome cisplatin resistance by increasing cellular uptake, targeting mitochondria, and inducing cell necrosis.

Graphical abstract: A mitochondria-targeting hetero-binuclear Ir(iii)–Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells

Supplementary files

Article information

Article type
Communication
Submitted
08 Apr 2018
Accepted
25 May 2018
First published
25 May 2018

Chem. Commun., 2018,54, 6268-6271

A mitochondria-targeting hetero-binuclear Ir(III)–Pt(II) complex induces necrosis in cisplatin-resistant tumor cells

C. Ouyang, L. Chen, T. W. Rees, Y. Chen, J. Liu, L. Ji, J. Long and H. Chao, Chem. Commun., 2018, 54, 6268 DOI: 10.1039/C8CC02795A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements